Delivery Order SPE2DR25D1053-SPE2DR26FT652
- Not listed
- The Defense Logistics Agency awarded a $3,273.32 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Topiramate is a generic anticonvulsant and mood-stabilizing medication commonly used in military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count) valued at $8,281.87 under a firm fixed-price contract type. The award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract and reflects the agency's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 mg Topiramate ER capsules. The $48,858.73 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $4,798.45. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,795.70 firm-fixed-price contract is for the supply of Topiramate ER 50 mg capsules, a medication used to treat certain types of seizures. The contract has an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.48 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Topiramate ER 25 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations center. This...
- The Defense Logistics Agency awarded a $6,774.81 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and active through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $5,421.03. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, with an ultimate completion date of August 26, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a contract ceiling value of $8,032.67. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $6,195.98 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. The delivery order represents a child contract action under...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT652Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Topiramate ER 50 mg capsules (30-count bottles) valued at $9,567.81 under a firm fixed-price contract. The award was made on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a non-set-aside, competitively awarded delivery order, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Topiramate is a generic anticonvulsant medication commonly used in federal military and veteran healthcare systems for neurological and pain management applications. This delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's ability to fulfill this delivery order demonstrates its established capability and ongoing role as a primary pharmaceutical supplier within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 11/5/25 |